Rocket Lab beat on sales and beat on earnings this week -- and its stock price went down. The company will delay Neutron's first launch into 2026. Rocket Lab still plans to launch more than 20 ...
Rocket Lab remains a speculative stock, unsuitable for risk-averse investors. Its valuation is stretched, with an EV/S ratio of 44.70, far above industry medians, reflecting high expectations for ...
Rocket Lab delivered record Q3 revenue of $155.1M, up 48% YoY, and beat EPS and revenue estimates, driving a 7% stock gain. RKLB's growth is fueled by strong Electron launch demand, aggressive ...
Rocket Lab's upcoming Neutron test is crucial for the company's development. Over the long term, it could help Rocket Lab deploy its own satellite constellation. However, the stock currently trades at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results